Page last updated: 2024-10-20

thiamine and Deafness

thiamine has been researched along with Deafness in 36 studies

thiamine(1+) : A primary alcohol that is 1,3-thiazol-3-ium substituted by (4-amino-2-methylpyrimidin-5-yl)methyl, methyl and 2-hydroxyethyl groups at positions 3, 4 and 5, respectively.

Deafness: A general term for the complete loss of the ability to hear from both ears.

Research Excerpts

ExcerptRelevanceReference
" Thiamine-responsive megaloblastic anaemia (TRMA), due to mutations in the thiamine transporter SLC19A2, is associated with the classical clinical triad of diabetes, deafness, and megaloblastic anaemia."8.88Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia. ( Abdullah, M; Ellard, S; Flanagan, SE; Grulich-Henn, J; Habeb, AM; Hattersley, AT; Hussain, K; Matyka, K; Patch, AM; Pomahacova, R; Shaw-Smith, C, 2012)
"5 years, because of the presence of diabetes and sensorineural deafness, she was diagnosed with TRMA syndrome and started treatment with thiamine-HCl, followed very early by benzoyloxymethyl-thiamine (BOM-T)."8.80Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome. ( Franzese, A; Poggi, V; Tenore, A; Valerio, G, 1998)
"Thiamine-responsive megaloblastic anaemia syndrome (TRMA) is the association of diabetes mellitus, anaemia and deafness, due to mutations in SLC19A2, encoding a thiamine transporter protein."7.73Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. ( Ariyawansa, I; Barrett, TG; Lo, IF; Minton, JA; Ricketts, CJ; Samuel, J; Wales, JK, 2006)
"Thiamine-responsive megaloblastic anaemia (TRMA) syndrome with diabetes and deafness was found in two patients from a Tunisian kindred."7.71A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome. ( Belhani, A; Berul, CI; Fleming, JC; Gritli, S; Guannouni, S; Hafsia, R; Hamdi, M; Jilani, SB; Neufeld, EJ; Omar, S; Steinkamp, MP; Tartaglini, E, 2001)
"Thiamine-responsive megaloblastic anemia (TRMA, also known as Rogers syndrome, OMIM 249270) is a rare autosomal recessive disorder characterized by a triad of megaloblastic anemia, diabetes mellitus, and sensorineural deafness."7.70Refined mapping of the gene for thiamine-responsive megaloblastic anemia syndrome and evidence for genetic homogeneity. ( Barrett, T; Cohen, N; Mandel, H; Neufeld, EJ; Nosaka, K; Raz, T; Szargel, R; Viana, MB, 1998)
"We have investigated the cellular pathology of the syndrome called thiamine-responsive megaloblastic anemia (TRMA) with diabetes and deafness."7.70Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts. ( Baker, MA; Cohen, N; Fleming, JC; Neufeld, EJ; Sakamoto, M; Stagg, AR, 1999)
"Thiamine-responsive megaloblastic anaemia syndrome (TRMA; MIM 249270) is an autosomal recessive disorder with features that include megaloblastic anaemia, mild thrombocytopenia and leucopenia, sensorineural deafness and diabetes mellitus."7.70Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. ( Banikazemi, M; Desnick, RJ; Diaz, GA; Gelb, BD; Oishi, K, 1999)
"Thiamine-responsive megaloblastic anaemia (TRMA), also known as Rogers syndrome, is an early onset, autosomal recessive disorder defined by the occurrence of megaloblastic anaemia, diabetes mellitus and sensorineural deafness, responding in varying degrees to thiamine treatment (MIM 249270)."7.70Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. ( Baron, D; Barrett, T; Cohen, N; Gregory, S; Labay, V; Mandel, H; McDonald, L; Nosaka, K; Raz, T; Shalata, A; Szargel, R; Williams, H, 1999)
"Thiamine-responsive megaloblastic anaemia with diabetes and deafness (TRMA; MIM 249270) is an autosomal recessive disease thought to be due to a defect in thiamine (vitamin B1) transport."7.70The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. ( Cohen, N; Fleming, JC; Neufeld, EJ; Schorderet, DF; Steinkamp, MP; Tartaglini, E, 1999)
"Three brothers with diabetes mellitus, thiamine-responsive megaloblastic anemia, and sensorineural deafness are reported."7.67Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity. ( Abboud, MR; Alexander, D; Najjar, SS, 1985)
"Wolfram syndrome, Kearns-Sayre syndrome, thiamine-responsive megaloblastic anemia, and maternally inherited diabetes and deafness are genetic disorders characterized by diabetes, impaired hearing, and vision."5.22Diabetes Out-of-the-Box: Diabetes Mellitus and Impairment in Hearing and Vision. ( Gruber, N; Pinhas-Hamiel, O, 2022)
" Thiamine-responsive megaloblastic anaemia (TRMA), due to mutations in the thiamine transporter SLC19A2, is associated with the classical clinical triad of diabetes, deafness, and megaloblastic anaemia."4.88Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia. ( Abdullah, M; Ellard, S; Flanagan, SE; Grulich-Henn, J; Habeb, AM; Hattersley, AT; Hussain, K; Matyka, K; Patch, AM; Pomahacova, R; Shaw-Smith, C, 2012)
"5 years, because of the presence of diabetes and sensorineural deafness, she was diagnosed with TRMA syndrome and started treatment with thiamine-HCl, followed very early by benzoyloxymethyl-thiamine (BOM-T)."4.80Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome. ( Franzese, A; Poggi, V; Tenore, A; Valerio, G, 1998)
"Individuals with thiamine-responsive megaloblastic anemia (TRMA) mainly manifest macrocytic anemia, sensorineural deafness, ocular complications, and nonautoimmune diabetes."4.31An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment. ( Arrigoni, F; Bonfanti, R; Di Candia, F; Di Iorio, V; Fedi, L; Franzese, A; Iafusco, F; Iovino, C; Malesci, R; Mozzillo, E; Rigamonti, A; Rosanio, FM; Simonelli, F; Tinto, N, 2023)
"Thiamine-responsive megaloblastic anaemia syndrome (TRMA) is the association of diabetes mellitus, anaemia and deafness, due to mutations in SLC19A2, encoding a thiamine transporter protein."3.73Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families. ( Ariyawansa, I; Barrett, TG; Lo, IF; Minton, JA; Ricketts, CJ; Samuel, J; Wales, JK, 2006)
"Thiamine-responsive megaloblastic anaemia (TRMA) syndrome with diabetes and deafness was found in two patients from a Tunisian kindred."3.71A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome. ( Belhani, A; Berul, CI; Fleming, JC; Gritli, S; Guannouni, S; Hafsia, R; Hamdi, M; Jilani, SB; Neufeld, EJ; Omar, S; Steinkamp, MP; Tartaglini, E, 2001)
"Thiamine-responsive megaloblastic anemia (TRMA, also known as Rogers syndrome, OMIM 249270) is a rare autosomal recessive disorder characterized by a triad of megaloblastic anemia, diabetes mellitus, and sensorineural deafness."3.70Refined mapping of the gene for thiamine-responsive megaloblastic anemia syndrome and evidence for genetic homogeneity. ( Barrett, T; Cohen, N; Mandel, H; Neufeld, EJ; Nosaka, K; Raz, T; Szargel, R; Viana, MB, 1998)
"We have investigated the cellular pathology of the syndrome called thiamine-responsive megaloblastic anemia (TRMA) with diabetes and deafness."3.70Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts. ( Baker, MA; Cohen, N; Fleming, JC; Neufeld, EJ; Sakamoto, M; Stagg, AR, 1999)
"Thiamine-responsive megaloblastic anaemia syndrome (TRMA; MIM 249270) is an autosomal recessive disorder with features that include megaloblastic anaemia, mild thrombocytopenia and leucopenia, sensorineural deafness and diabetes mellitus."3.70Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome. ( Banikazemi, M; Desnick, RJ; Diaz, GA; Gelb, BD; Oishi, K, 1999)
"Thiamine-responsive megaloblastic anaemia (TRMA), also known as Rogers syndrome, is an early onset, autosomal recessive disorder defined by the occurrence of megaloblastic anaemia, diabetes mellitus and sensorineural deafness, responding in varying degrees to thiamine treatment (MIM 249270)."3.70Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness. ( Baron, D; Barrett, T; Cohen, N; Gregory, S; Labay, V; Mandel, H; McDonald, L; Nosaka, K; Raz, T; Shalata, A; Szargel, R; Williams, H, 1999)
"Thiamine-responsive megaloblastic anaemia with diabetes and deafness (TRMA; MIM 249270) is an autosomal recessive disease thought to be due to a defect in thiamine (vitamin B1) transport."3.70The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter. ( Cohen, N; Fleming, JC; Neufeld, EJ; Schorderet, DF; Steinkamp, MP; Tartaglini, E, 1999)
"Thiamine responsive megaloblastic anemia (TRMA) is an autosomal recessive disorder with a triad of symptoms: megaloblastic anemia, deafness, and non-type 1 diabetes mellitus."3.70The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families. ( Anbinder, Y; Baron, D; Barrett, T; Baruchel, A; Cayuela, JM; Cohen, N; Labay, V; Mandel, H; Rabl, W; Raz, T; Szargel, R; Viana, MB, 2000)
"We have investigated thiamine metabolism and transport in the erythrocytes of two patients from unrelated families with thiamine responsive megaloblastic anaemia associated with diabetes mellitus and sensorineural deafness."3.67Studies on thiamine metabolism in thiamine-responsive megaloblastic anaemia. ( Andria, G; De Vizia, B; Longo, G; Patrini, C; Poggi, V; Rindi, G, 1989)
"Three brothers with diabetes mellitus, thiamine-responsive megaloblastic anemia, and sensorineural deafness are reported."3.67Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity. ( Abboud, MR; Alexander, D; Najjar, SS, 1985)

Research

Studies (36)

TimeframeStudies, this research(%)All Research%
pre-199018 (50.00)18.7374
1990's7 (19.44)18.2507
2000's6 (16.67)29.6817
2010's2 (5.56)24.3611
2020's3 (8.33)2.80

Authors

AuthorsStudies
Gruber, N1
Pinhas-Hamiel, O1
Khaliq, S1
Di Candia, F1
Di Iorio, V1
Tinto, N1
Bonfanti, R1
Iovino, C1
Rosanio, FM1
Fedi, L1
Iafusco, F1
Arrigoni, F1
Malesci, R1
Simonelli, F1
Rigamonti, A1
Franzese, A2
Mozzillo, E1
Bergmann, AK1
Sahai, I1
Falcone, JF1
Fleming, J1
Bagg, A1
Borgna-Pignati, C1
Casey, R1
Fabris, L1
Hexner, E1
Mathews, L1
Ribeiro, ML1
Wierenga, KJ1
Neufeld, EJ5
Zhang, SQ1
Guan, YT1
Shaw-Smith, C1
Flanagan, SE1
Patch, AM1
Grulich-Henn, J1
Habeb, AM1
Hussain, K1
Pomahacova, R1
Matyka, K1
Abdullah, M1
Hattersley, AT1
Ellard, S1
OHZAWA, R1
NAKAMURA, M1
WILLIAMS, HL1
MAHER, FT1
CORBIN, KB1
BROWN, JR1
BROWN, HA1
HEDGECOCK, LD1
NAKAHARA, K1
MARUYAMA, R1
TAKENOUE, T1
GOTO, K1
SEKIYA, T1
WATANABE, T1
KANEKO, Z1
OSHITA, F1
NIWA, O1
YASUDA, Y1
NUMAKURA, M1
HONMA, T1
ONUMA, M1
OSAWA, R1
Davidson, A1
Hartley, PS1
Berman, P1
Shuttleworth, MH1
Ricketts, CJ1
Minton, JA1
Samuel, J1
Ariyawansa, I1
Wales, JK1
Lo, IF1
Barrett, TG1
Subramanian, VS1
Marchant, JS1
Said, HM1
TOMOMATU, S1
Haworth, C1
Evans, DI2
Mitra, J1
Wickramasinghe, SN1
Valerio, G1
Poggi, V2
Tenore, A1
Raz, T3
Barrett, T3
Szargel, R3
Mandel, H3
Nosaka, K2
Viana, MB3
Cohen, N5
Stagg, AR1
Fleming, JC3
Baker, MA1
Sakamoto, M1
Diaz, GA1
Banikazemi, M1
Oishi, K1
Desnick, RJ1
Gelb, BD1
Labay, V2
Baron, D2
Williams, H1
McDonald, L1
Shalata, A1
Gregory, S1
Tartaglini, E2
Steinkamp, MP2
Schorderet, DF1
Anbinder, Y1
Rabl, W1
Baruchel, A1
Cayuela, JM1
Gritli, S1
Omar, S1
Guannouni, S1
Berul, CI1
Hafsia, R1
Jilani, SB1
Belhani, A1
Hamdi, M1
Carvalho, RI1
Rindi, G1
Patrini, C1
De Vizia, B1
Longo, G1
Andria, G1
Abboud, MR1
Alexander, D1
Najjar, SS1
Ouchi, H1
Ishida, H1
Otani, I1
Mizuno, S1
Hattori, M1
Watanabe, Y1
Ozaki, M1
Naito, T1
Porter, FS1
Rogers, LE1
Sidbury, JB1
Hine, S1
Koike, Y1

Reviews

3 reviews available for thiamine and Deafness

ArticleYear
Diabetes Out-of-the-Box: Diabetes Mellitus and Impairment in Hearing and Vision.
    Current diabetes reports, 2022, Volume: 22, Issue:9

    Topics: Anemia, Megaloblastic; Deafness; Diabetes Mellitus; Diabetes Mellitus, Type 2; Hearing; Hearing Loss

2022
Recessive SLC19A2 mutations are a cause of neonatal diabetes mellitus in thiamine-responsive megaloblastic anaemia.
    Pediatric diabetes, 2012, Volume: 13, Issue:4

    Topics: Anemia, Megaloblastic; Consanguinity; Deafness; Diabetes Mellitus; Genes, Recessive; Homozygote; Hum

2012
Long-term follow-up of diabetes in two patients with thiamine-responsive megaloblastic anemia syndrome.
    Diabetes care, 1998, Volume: 21, Issue:1

    Topics: Adolescent; Anemia, Megaloblastic; Blood Glucose; Child, Preschool; Deafness; Diabetes Mellitus, Typ

1998

Other Studies

33 other studies available for thiamine and Deafness

ArticleYear
Thiamine responsive megaloblastic anaemia complicated with acute Parvovirus infection: A case report.
    JPMA. The Journal of the Pakistan Medical Association, 2023, Volume: 73, Issue:1

    Topics: Adolescent; Anemia, Megaloblastic; Deafness; Diabetes Mellitus; Hearing Loss, Sensorineural; Humans;

2023
An Italian case series' description of thiamine responsive megaloblastic anemia syndrome: importance of early diagnosis and treatment.
    Italian journal of pediatrics, 2023, Nov-30, Volume: 49, Issue:1

    Topics: Adult; Anemia, Megaloblastic; Child; Deafness; Diabetes Mellitus; Early Diagnosis; Hearing Loss, Sen

2023
Thiamine-responsive megaloblastic anemia: identification of novel compound heterozygotes and mutation update.
    The Journal of pediatrics, 2009, Volume: 155, Issue:6

    Topics: Adult; Anemia, Megaloblastic; Child; Child, Preschool; Cohort Studies; Deafness; Diabetes Mellitus;

2009
Acute bilateral deafness as the first symptom of Wernicke encephalopathy.
    AJNR. American journal of neuroradiology, 2012, Volume: 33, Issue:3

    Topics: Brain; Deafness; Humans; Magnetic Resonance Imaging; Male; Thiamine; Treatment Outcome; Wernicke Enc

2012
[CLINICAL TRIAL OF NEUVITA IN THE TREATMENT OF NERVE DEAFNESS].
    Jibi inkoka Otolaryngology, 1963, Volume: 35

    Topics: Deafness; Hearing Loss; Humans; Japan; Sulfides; Thiamine

1963
ERIODICTYOL GLYCOSIDE IN THE TREATMENT OF MENI'ERE'S DISEASE.
    The Annals of otology, rhinology, and laryngology, 1963, Volume: 72

    Topics: Ascorbic Acid; Choline; Deafness; Flavanones; Flavonoids; Glycosides; Inositol; Meniere Disease; Met

1963
[2 CASES OF SLIGHT PERCEPTIVE DEAFNESS CURED BY ASPARA TABLETS].
    Jibi inkoka Otolaryngology, 1963, Volume: 35

    Topics: Aspartic Acid; Chondroitin; Deafness; Hearing Loss; Hearing Loss, Sensorineural; Humans; Tablets; Th

1963
[CASE OF HERPES ZOSTER OTICUS ACCOMPANIED BY MULTIPLE CRANIAL NERVE PARALYSIS].
    Jibi inkoka Otolaryngology, 1964, Volume: 36

    Topics: Adenosine Triphosphate; Arthritis; Arthritis, Rheumatoid; Arthroplasty; Cochlear Nerve; Cranial Nerv

1964
[THERAPEUTIC RESULTS IN THE TREATMENT OF NERVE DEAFNESS WITH THE COMBINED USE OF NOIVITA AND VERINA].
    Jibi inkoka Otolaryngology, 1964, Volume: 36

    Topics: Adenosine Triphosphate; Chondroitin; Deafness; Drug Therapy; Hearing Loss; Niacin; Nicotinic Acids;

1964
[The use of sugarcoated alinamin in massive doses in the treatment of inner ear deafness and tinnitus aurium].
    Jibi inkoka Otolaryngology, 1962, Volume: 34

    Topics: Deafness; Ear, Inner; Hearing Loss; Hearing Loss, Sensorineural; Humans; Thiamine; Tinnitus

1962
[Experience in the use of ATP-2Na (Adephos KOWA) in inner ear deafness and tinnitus].
    Jibi inkoka Otolaryngology, 1962, Volume: 34

    Topics: Adenine Nucleotides; Adenosine Triphosphate; Deafness; Ear, Inner; Hearing Loss; Hearing Loss, Senso

1962
[Results in biotamin treatment of perceptual deafness].
    Jibi inkoka Otolaryngology, 1962, Volume: 34

    Topics: Deafness; Hearing Loss; Humans; Thiamine

1962
Megaloblastic anaemia, diabetes and deafness in a 2-year-old child.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2005, Volume: 95, Issue:9

    Topics: Anemia, Megaloblastic; Child, Preschool; Deafness; Diabetes Mellitus, Type 1; Female; Humans; Thiami

2005
Thiamine-responsive megaloblastic anaemia syndrome: long-term follow-up and mutation analysis of seven families.
    Acta paediatrica (Oslo, Norway : 1992), 2006, Volume: 95, Issue:1

    Topics: Adolescent; Adult; Anemia, Megaloblastic; Child; Child, Preschool; Deafness; Diabetes Mellitus; DNA

2006
Targeting and intracellular trafficking of clinically relevant hTHTR1 mutations in human cell lines.
    Clinical science (London, England : 1979), 2007, Volume: 113, Issue:2

    Topics: Anemia, Megaloblastic; Cell Line; Cytoplasm; Deafness; Diabetes Mellitus; DNA Mutational Analysis; F

2007
[Methods of diagnosis of nervous deafness due to a lack of Vitamin B1, and results in the treatment of such a condition].
    Fukuoka igaku zasshi = Hukuoka acta medica, 1948, Volume: 39, Issue:2

    Topics: Deafness; Humans; Thiamine; Thiazoles

1948
Thiamine responsive anaemia: a study of two further cases.
    British journal of haematology, 1982, Volume: 50, Issue:4

    Topics: Anemia, Macrocytic; Bone Marrow; Child; Deafness; Deoxyuridine; Diabetes Mellitus; DNA; Erythroblast

1982
Refined mapping of the gene for thiamine-responsive megaloblastic anemia syndrome and evidence for genetic homogeneity.
    Human genetics, 1998, Volume: 103, Issue:4

    Topics: Anemia, Megaloblastic; Child; Child, Preschool; Chromosome Mapping; Chromosomes, Human, Pair 1; Deaf

1998
Defective high-affinity thiamine transporter leads to cell death in thiamine-responsive megaloblastic anemia syndrome fibroblasts.
    The Journal of clinical investigation, 1999, Volume: 103, Issue:5

    Topics: Anemia, Megaloblastic; Apoptosis; Carrier Proteins; Cells, Cultured; Deafness; Diabetes Mellitus; Fi

1999
Mutations in a new gene encoding a thiamine transporter cause thiamine-responsive megaloblastic anaemia syndrome.
    Nature genetics, 1999, Volume: 22, Issue:3

    Topics: Amino Acid Sequence; Anemia, Megaloblastic; Base Sequence; Carrier Proteins; Cloning, Molecular; Dea

1999
Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness.
    Nature genetics, 1999, Volume: 22, Issue:3

    Topics: Amino Acid Sequence; Anemia, Megaloblastic; Animals; Base Sequence; Carrier Proteins; Cricetinae; De

1999
The gene mutated in thiamine-responsive anaemia with diabetes and deafness (TRMA) encodes a functional thiamine transporter.
    Nature genetics, 1999, Volume: 22, Issue:3

    Topics: Amino Acid Sequence; Anemia, Megaloblastic; Animals; Base Sequence; Carrier Proteins; Cell Line; Dea

1999
The spectrum of mutations, including four novel ones, in the thiamine-responsive megaloblastic anemia gene SLC19A2 of eight families.
    Human mutation, 2000, Volume: 16, Issue:1

    Topics: Alleles; Anemia, Megaloblastic; Carrier Proteins; Deafness; Diabetes Mellitus; DNA Mutational Analys

2000
A novel mutation in the SLC19A2 gene in a Tunisian family with thiamine-responsive megaloblastic anaemia, diabetes and deafness syndrome.
    British journal of haematology, 2001, Volume: 113, Issue:2

    Topics: Anemia, Megaloblastic; Bone Marrow Cells; Cardiomyopathy, Dilated; Carrier Proteins; Child, Preschoo

2001
Thiamine-responsive megaloblastic anemia, sensorineural deafness, and diabetes mellitus: A new syndrome?
    The Journal of pediatrics, 1978, Volume: 93, Issue:2

    Topics: Adult; Anemia, Macrocytic; Anemia, Megaloblastic; Child; Deafness; Diabetes Mellitus; Diabetes Melli

1978
Thiamine responsive anaemia.
    British journal of haematology, 1991, Volume: 78, Issue:1

    Topics: Anemia; Deafness; Female; Humans; Thiamine; Thiamine Deficiency

1991
Studies on thiamine metabolism in thiamine-responsive megaloblastic anaemia.
    European journal of pediatrics, 1989, Volume: 148, Issue:4

    Topics: Anemia, Macrocytic; Anemia, Megaloblastic; Child, Preschool; Deafness; Diabetes Mellitus, Type 1; Er

1989
Diabetes mellitus, thiamine-dependent megaloblastic anemia, and sensorineural deafness associated with deficient alpha-ketoglutarate dehydrogenase activity.
    The Journal of pediatrics, 1985, Volume: 107, Issue:4

    Topics: Adolescent; Anemia, Macrocytic; Anemia, Megaloblastic; Child; Child, Preschool; Deafness; Diabetes M

1985
[Effects of vitamin B1 derivatives on the hearing disorders caused by kanamycin. 2].
    Virology, 1970, Volume: 42, Issue:1

    Topics: Animals; Cochlea; Deafness; Kanamycin; Microscopy, Phase-Contrast; Rabbits; Thiamine

1970
[Case of recurrent deafness without vertigo].
    Nihon Jibiinkoka Gakkai kaiho, 1969, Volume: 72, Issue:11

    Topics: Acetazolamide; Adult; Deafness; Hearing Tests; Humans; Male; Thiamine; Vertigo

1969
Thiamine-responsive megaloblastic anemia.
    The Journal of pediatrics, 1969, Volume: 74, Issue:4

    Topics: Amino Acids; Anemia, Macrocytic; Bone Marrow Examination; Child; Deafness; Diabetes Complications; D

1969
[Thiamine disulfide-O, O'-bismonophosphate (VMT-908) in treatment of nerve deafness].
    Jibi inkoka Otolaryngology, 1965, Volume: 37, Issue:11

    Topics: Deafness; Humans; Thiamine

1965
[Thiamine disulfide bis-monophosphate in the field of otolaryngology].
    Jibi inkoka Otolaryngology, 1966, Volume: 38, Issue:2

    Topics: Deafness; Facial Paralysis; Humans; Olfaction Disorders; Thiamine

1966